Alveolar bone destruction is a hallmark of destructive periodontitis that stems from an imbalance between bone anabolic and catabolic effects. 5 Alveolar bone remodeling involves cell-cell communication between osteoclasts and osteoblasts, which is rigorously regulated by a trimolecular complex composed of receptor activator nuclear factor κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG). 6 Oral fluids, such as gingival crevicular fluid, contain molecules from the periodontal disease process that serve as potential biomarkers. 7 Among the several biomarkers, the RANK/RANKL/ OPG complex has therapeutic and diagnostic value in periodontal disease pathogenesis. 8 Sclerostin (SOST) is a secreted glycoprotein product of the SOST gene, which has a negative regulation on bone mass and osteoblast differentiation, resulting in an inhibition of bone formation. 9 Furthermore, mouse osteocyte cell cultures treated with recombinant human SOST demonstrated a dose-dependent upregulation of RANKL mRNA and downregulation of OPG mRNA, suggesting a catabolic action of SOST on bone metabolism 10 Interestingly, in a POSTN knockout mice model, deleting the SOST gene or blocking SOST function by using monoclonal antibodies significantly restored bone and periodontal ligament defects. 11 Therefore, a study of these molecules can provide a better understanding of their role in the underlying disease process. The aim of the present study was to compare their expression in healthy gingiva and sites with severe chronic periodontitis, 12 and to determine the expression profile of SOST, POSTN, RANK, and RANKL genes in gingival tissue samples from sites with healthy gingiva and severe chronic periodontitis.
| MATERIAL S AND ME THODS
The present case-control study design was selected to achieve the mentioned objective. The number of samples required was established based on data published in a study by Napimoga et al.
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A sample size of 25 per group was estimated, considering 90% power, 5% α value, and .5 mean difference.
| Study participants
The Institutional Ethics Committee of Sri Ramachandra University 
| Tissue sampling
A local anesthetic solution (2% lidocaine with 1: 2 00 000 adrena- 
| Gene expression analysis
Total RNA was isolated from a standardized weight (100 mg) of each gingival tissue using the TRIzol method (RNAiso Plus; TaKaRa Bio, Shiga, Japan). Reverse transcriptase polymerase chain reaction (PCR) program was then run for cDNA conversion, using a highcapacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA) as per the manufacturer's protocols. The SOST, POSTN, RANK, and RANKL primers were chosen from published literature (Table 1) . [15] [16] [17] Real-time PCR assay with SYBR green (Applied Biosystems, Foster City, CA, USA) was then conducted to measure the relative gene expression. Real-time PCR assays were carried out using a 7500 Fast Real-Time PCR System and analyzed with SDS 
| Statistical analysis

| RE SULTS
The demographic features and clinical data of the study population are summarized in Table 2 
| D ISCUSS I ON
The analysis of gene expression levels in gingival tissue samples from control and severe chronic periodontitis-affected patients showed a significant upregulation of SOST, RANK, and RANKL gene expression, and a concomitant downregulation of POSTN gene expression in sites with severe chronic periodontitis.
In periodontal disease, the gingival cells play a direct role in triggering a host response, and the resulting disruption in the homeostatic mechanism results in altered bone remodelling. 12 The key 
TA B L E 1 Oligonucleotide primers used for real-time polymerase chain reaction assays
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As well as serving as a structural molecule, POSTN interacts with integrin receptors αVβ3 and αVβ5, and regulates the Wnt/β-catenin signaling pathway, which in turn stimulates osteoblast formation. 28 Furthermore, bone anabolic effects of POSTN occurs as a result of the downregulation of SOST, which subsequently lead to the activation of Wnt/β-catenin signaling. 29 Mouse studies have revealed that the upregulation of POSTN expression results in the inhibition of SOST by acting via Wnt/β-catenin signaling.
This POSTN-SOST-Wnt signaling results in increased osteoblastic activity and reduced bone loss. 30 The findings of our study also provide supportive evidence for an inverse relationship between SOST and POSTN gene expression at sites with severe chronic periodontitis.
However, the present study has several limitations: (a) circulating protein levels of POSTN, SOST, RANK, and RANKL in saliva/gingival crevicular fluid were not analyzed and correlated with the gene expression in the chronic periodontitis group; and (b) SOST levels
could not be associated with the RANKL/OPG ratio, as the protein levels were not determined. In conclusion, within the limitations of the present study, the differential expression of the selected genes suggests that the proteins that they encode for can undergo significant quantitative changes during periodontitis pathogenesis. To the best of our knowledge, this is the first study that has compared the relative expression levels of POSTN and SOST genes in gingival tissue from sites with severe chronic periodontitis.
